Dose-Dependent Effects of Low-Intensity Focused Ultrasound
Part of paid clinical trials in Tulsa, Oklahoma.
- Sponsor
- Laureate Institute for Brain Research, Inc.
- Study ID
- NCT07099950
- Status
- Recruiting
Conditions
- Healthy Controls
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Accepted
Interventions
- Low-intensity focused ultrasound — OTHER80-second stimulus with an estimated tissue ISSPA=2.26 W/cm2, administered as a single dose (1-epoch), or in multiple doses (3-epoch).
Study Details
Low-intensity focused ultrasound (LIFU) has emerged as a tool to modulate the activity of deep brain structures noninvasively and reversibly, with anatomical precision. Following the results of a pilot study in which the investigators observed target engagement when LIFU was applied to the anterior limb of the internal capsule, the investigators now propose to determine the dose-response relationships of LIFU when applied to deep white matter tracts of the human brain. The investigators hope a successful study will be rapidly translatable into clinical trials seeking to understand mechanistic brain circuit-symptom relationships in major psychiatric disorders.
Key Dates
- Start date
- Apr 22, 2025
- Status verified
- Oct 2025
- Primary completion
- Aug 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 66 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Single Dose (1-epoch)An 80-second train of 20-millisecond bursts of ultrasound (0.5 MHz), repeated every 200 milliseconds (400 bursts). It is estimated a 75% tissue attenuation of energy when the ultrasound wave reaches its target, therefore the investigators will set the free-field Intensity Spatial-Peak Pulse-Average (ISPPA) at 9.04 Watt /cm2 or 518 kPascal (to achieve 2.26 Watt/cm2 estimated derated ISPPA). Any modeling of actual energy delivery will be made a posteriori employing BabelBrain® software embedded in the Brainsight® neuronavigation system.
- Experimental: Multiple Doses (3-epoch)Three 80-second trains of 20-millisecond bursts of ultrasound (0.5 MHz), repeated every 200 milliseconds (400 bursts) will be administered, separated by 30 seconds each. Again, it is estimated a 75% tissue attenuation of energy when the ultrasound wave reaches its target, therefore the investigators will set the free-field Intensity Spatial-Peak Pulse-Average (ISPPA) at 9.04 Watt /cm2 or 518 kPascal (to achieve 2.26 Watt/cm2 derated ISPPA). See above for a posteriori acoustic energy modeling.
Primary Outcome Measure
Post-Sonication Changes in Tissue Engagement [ Time Frame: Pre- vs up to 30 minutes post-sonication for 1-epoch vs 3-epoch LIFU. ]
Central Contacts
- Salvador M Guinjoan, MD, PhD918-502-5119
- Danielle E Clark, MA918-701-9610
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Laureate Institute for Brain Research | Tulsa | Oklahoma | 74136 |
Find similar trials in Tulsa, OK
Related Studies
- Measuring the Healthy Pediatric Inflammatory Response to Vaccination.Enrolling By Invitation · Mayo Clinic · Rochester, Minnesota
- Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET StudyRecruiting · Yale University · New Haven, Connecticut
- HA35 Acute Alcohol StudyEARLY_PHASE1 · Recruiting · The Cleveland Clinic · Cleveland, Ohio
- A Repository to Study Host-Microbiome Interactions in Health and DiseaseRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland